Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
919 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Arthur J E Child Comprehensive Cancer Centre
Calgary, Alberta, Canada
- Cross Cancer Institute
Edmonton, Alberta, Canada
- Bcca-Fraser Valley Cancer Centre
Surrey, British Columbia, Canada
- Bcca-Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- the Moncton Hospital
Moncton, New Brunswick, Canada
- Atlantic Health Sciences Corporation-Saint John Regional Hospital
Saint John, New Brunswick, Canada
- Doctor H. Bliss Murphy Cancer Centre
St. John's, Newfoundland and Labrador, Canada
- Juravinski Cancer Centre at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Waterloo Regional Health Network
Kitchener, Ontario, Canada
- London Regional Cancer Program
London, Ontario, Canada
- Stronach Regional Health Centre at Southlake
Newmarket, Ontario, Canada
- Algoma District Cancer Program Sault Area Hospital
Sault Ste. Marie, Ontario, Canada
- Humber River Hospital
Toronto, Ontario, Canada
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
- Hopital de la Cite-de-la-Sante
Laval, Quebec, Canada
- Hopital Du Sacre-Coeur de Montreal
Montreal, Quebec, Canada
- Jewish General Hospital
Montreal, Quebec, Canada
- the Research Institute of the Mcgill University Health Centre (muhc)
Montreal, Quebec, Canada
- Chu de Quebec-Hopital Du Saint-Sacrement (hss)
Québec, Quebec, Canada
- Allan Blair Cancer Centre
Regina, Saskatchewan, Canada
- Cancer Center-Metro Medical Center Bayamon
Bayamón, Puerto Rico
- Doctors Cancer Center
Manati, Puerto Rico
- San Juan City Hospital
San Juan, Puerto Rico
- San Juan Community Oncology Group
San Juan, Puerto Rico
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Southern Cancer Center Pc-Daphne
Daphne, Alabama, United States
- Southern Cancer Center Pc-Mobile
Mobile, Alabama, United States
- Southern Cancer Center Pc-Providence
Mobile, Alabama, United States
- Southern Cancer Center Pc-Springhill
Mobile, Alabama, United States
- University of South Alabama Mitchell Cancer Institute
Mobile, Alabama, United States
- Alaska Oncology and Hematology Llc
Anchorage, Alaska, United States
- Anchorage Oncology Centre
Anchorage, Alaska, United States
- Katmai Oncology Group
Anchorage, Alaska, United States
- Providence Alaska Medical Center
Anchorage, Alaska, United States
- Fairbanks Memorial Hospital
Fairbanks, Alaska, United States
- Banner Md Anderson Cancer Center
Gilbert, Arizona, United States
- Ctca at Western Regional Medical Center
Goodyear, Arizona, United States
- Banner University Medical Center - Tucson
Tucson, Arizona, United States
- University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- Nea Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro
Jonesboro, Arkansas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Jan 2017
- Primary completion
- 31 Aug 2026
- Completion
- 31 Aug 2026
- Last update posted
- 2 Jul 2026
- Registered enrollment
- 1,155
- Registry id
- NCT02954874
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.